Sernova Biotherapeutics Inc (SVA)

Currency in CAD
0.14
0.00(0.00%)
Closed·
SVA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.130.14
52 wk Range
0.120.21
Key Statistics
Bid/Ask
0.13 / 0.14
Prev. Close
0.14
Open
0.14
Day's Range
0.13-0.14
52 wk Range
0.12-0.21
Volume
161.77K
Average Volume (3m)
129.88K
1-Year Change
-9.6774%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SVA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.45
Upside
+221.43%
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 0.45
(+221.43% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Jun 12, 2026
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

SVA Income Statement

Compare SVA to Peers and Sector

Metrics to compare
SVA
Peers
Sector
Relationship
P/E Ratio
−4.4x−2.6x−0.4x
PEG Ratio
−0.090.000.00
Price/Book
−2.4x−0.5x2.6x
Price / LTM Sales
-1.9x3.0x
Upside (Analyst Target)
221.4%88.4%51.8%
Fair Value Upside
Unlock5.7%7.2%Unlock

Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is based in Mississauga, Canada.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
150.00K0.04%20.25K
Other Institutional Investors
0.000.00%0.00
Public Companies & Retail Investors
377.49M99.96%50.96M
Total
377.64M100.00%50.98M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
CATAM Asset Management AG0.04%150,00020
GFA International Fund0.04%150,00020

FAQ

What Is the Sernova Biotherapeutics (SVA) Stock Price Today?

The Sernova Biotherapeutics stock price today is 0.14 CAD.

What Stock Exchange Does Sernova Biotherapeutics Trade On?

Sernova Biotherapeutics is listed and trades on the Toronto Stock Exchange.

What Is the Stock Symbol for Sernova Biotherapeutics?

The stock symbol for Sernova Biotherapeutics is "SVA."

What Is the Sernova Biotherapeutics Market Cap?

As of today, Sernova Biotherapeutics market cap is 50.98M CAD.

What Is Sernova Biotherapeutics's Earnings Per Share (TTM)?

The Sernova Biotherapeutics EPS (TTM) is -0.04.

When Is the Next Sernova Biotherapeutics Earnings Date?

Sernova Biotherapeutics will release its next earnings report on Sep 10, 2026.

From a Technical Analysis Perspective, Is SVA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Sernova Biotherapeutics Stock Split?

Sernova Biotherapeutics has split 0 times.

How Many Employees Does Sernova Biotherapeutics Have?

Sernova Biotherapeutics has 8 employees.

What is the current trading status of Sernova Biotherapeutics (SVA)?

As of Jun 30, 2026, Sernova Biotherapeutics (SVA) is trading at a price of 0.14 CAD, with a previous close of 0.14 CAD. The stock has fluctuated within a day range of 0.13 CAD to 0.14 CAD, while its 52-week range spans from 0.12 CAD to 0.21 CAD.

What Is Sernova Biotherapeutics (SVA) Price Target According to Analysts?

The average 12-month price target for Sernova Biotherapeutics is 0.45 CAD, with a high estimate of 0.45 CAD and a low estimate of 0.45 CAD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +221.43% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.